| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Comprehensive loss | -80,735 | -73,680 | ||
| Net loss per common share, basic | - | -0.53 | ||
| Net loss per common share, diluted | - | -0.53 | ||
| Weighted average common shares outstanding, basic | - | 114,466,080 | ||
| Weighted average common shares outstanding, diluted | - | 114,466,080 | ||
| Net loss per common share, basic | -125.45 | - | ||
| Net loss per common share, diluted | -125.45 | - | ||
| Weighted average common shares outstanding, basic | 67,414 | - | ||
| Weighted average common shares outstanding, diluted | 67,414 | - | ||
Cogent Biosciences, Inc. (COGT)
Cogent Biosciences, Inc. (COGT)